Treatment of Fulminant Hepatic Failure in Rats Using a Bioartificial Liver Device Containing Porcine Hepatocytes Producing Interleukin-1 Receptor Antagonist
- 1 May 2006
- journal article
- research article
- Published by Mary Ann Liebert Inc in Tissue Engineering
- Vol. 12 (5), 1313-1323
- https://doi.org/10.1089/ten.2006.12.1313
Abstract
Fulminant hepatic failure (FHF) is a serious clinical condition that is associated with high mortality. There is evidence that FHF is an inflammatory disease, which is supported clinically by elevated serum levels of cytokines. In an effort to develop hepatocytes with additional functions for use in our bioartificial liver (BAL) device, we focused on interleukin-1 (IL-1) blockade as a therapeutic modality. Primary porcine hepatocytes were isolated from the livers of miniature swine and then transfected with an adenoviral vector encoding human interleukin-1 receptor antagonist (AdIL- 1Ra). The transfected hepatocytes secreted human IL-1Ra. These transfected hepatocytes were incorporated into a flat-plate BAL device to evaluate their efficacy in treating D-galactosamine (GalN)- induced FHF in a rat model. After extracorporeal perfusion with the BAL device containing the transfected hepatocytes, there were significant reductions in the plasma levels of hepatic enzymes (aspartate aminotransferase and alanine aminotransferase) and cytokines (IL-1 and IL-6), indicating a beneficial effect. Animal survival was significantly improved in the treated group compared to the control group. These experiments demonstrate that combining inflammatory cytokine blockade with a functional BAL device may be an effective therapeutic option in the treatment of FHF.Keywords
This publication has 37 references indexed in Scilit:
- Transfer Of The Interleukin-1 Receptor Antagonist Gene Into Rat Liver Abrogates Hepatic Ischemia-Reperfusion InjuryTransplantation, 2002
- Evidence of Porcine Endogenous Retroviruses in Porcine Factor VIII and Evaluation of Transmission to Recipients with HemophiliaThe Journal of Infectious Diseases, 2001
- Xenobiotic Metabolism by Cultured Primary Porcine HepatocytesTissue Engineering, 2000
- Baculovirus vectors repress phenobarbital-mediated gene induction and stimulate cytokine expression in primary cultures of rat hepatocytesGene Therapy, 2000
- DETOXIFYING ACTIVITY IN PIG LIVERS AND HEPATOCYTES INTENDED FOR XENOTHERAPY1Transplantation, 1999
- INTERLEUKIN 1 RECEPTOR BLOCKADE REDUCES TUMOR NECROSIS FACTOR PRODUCTION, TISSUE INJURY, AND MORTALITY AFTER HEPATIC ISCHEMIA-REPERFUSION IN THE RAT1Transplantation, 1997
- Orthotopic Liver Transplantation in Fulminant and Subfulminant Hepatitis The Paul Brousse ExperienceAnnals of Surgery, 1995
- Circulating proinflammatory cytokines (IL-1β, TNF-α, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitisClinical and Experimental Immunology, 1994
- Extent of the acute phase response in fulminant hepatic failure.Gut, 1994
- ENHANCED TUMOUR NECROSIS FACTOR AND INTERLEUKIN-1 IN FULMINANT HEPATIC FAILUREThe Lancet, 1988